For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240619:nRSS9595Sa&default-theme=true
RNS Number : 9595S R&Q Insurance Holdings Ltd 19 June 2024
The information contained within this announcement was deemed by the Company
to constitute inside information as stipulated under the UK Market Abuse
Regulation. With the publication of this announcement, this information is now
considered to be in the public domain.
R&Q Insurance Holdings Ltd
Update
19 June 2024
R&Q Insurance Holdings Ltd (AIM: RQIH) ("R&Q" or "the Company")
announced on 13 June 2024 an update on the proposed sale (the "Sale") of 100%
of R&Q's equity interest in Randall & Quilter America Holding Inc.,
the holding company of the Company's program management business Accredited,
to funds advised by Onex Corporation ("Onex").
The 13 June announcement explained that Onex had provided R&Q with a
proposed alternative transaction structure to that of the original Sale that
could be implemented in the event that the closing conditions to the original
Sale were not able to be satisfied (the "Alternative Proposal") and that the
Board was exploring and evaluating all options that may be available to the
Company (including the Alternative Proposal), whilst continuing discussions on
implementing the Sale on its original terms.
Following the Board's exploration and evaluation and taking all other relevant
factors into consideration, including the cash resources currently available
to the Company, the Board has concluded that the Alternative Proposal
represents the best option to secure value at this time.
The implementation of the Alternative Proposal will involve the Company filing
for a provisional liquidation in Bermuda and the Board expects the sale of
Accredited to Onex to then be implemented through that process. The
provisional liquidators would then look to realise value from the Company's
remaining assets, at the end of which the remaining Company would be wound up.
The Directors believe that, in those circumstances, there will be very little,
if any, chance of any value accruing to the Company's shareholders.
R&Q will now request that trading in the Company's ordinary shares on AIM
be suspended with immediate effect and will be filing for provisional
liquidation in Bermuda in due course. Notwithstanding any suspension of
trading in the Company's ordinary shares, the Company will continue to make
notifications as and when there are matters requiring disclosure in accordance
with the Company's obligations under the AIM Rules for Companies and/or the UK
Market Abuse Regulation.
Further announcements will be made, as appropriate, in due course.
-Ends-
Enquiries to:
R&Q Insurance Holdings Ltd
Tel: +44 (0)20 7780 5850
Jeff Hayman
William Spiegel
Tom Solomon
Fenchurch Advisory Partners LLP (Financial
Adviser) Tel: +44
(0)20 7382 2222
Kunal Gandhi
Brendan Perkins
John Sipp
Richard Locke
Tihomir Kerkenezov
Barclays Bank PLC (Financial Adviser and Joint
Broker) Tel: +44 (0)20 7632
2322
Gary Antenberg
Richard Bassingthwaighte
Anusuya Nayar Gupta
Grant Bickwit
Howden Tiger (Financial Adviser)
Tel : +44 (0)20 7398 4888
Rob
Bredahl
Leo
Beckham
Deutsche Numis (Nominated Adviser and Joint
Broker) Tel : +44 (0)20
7260 1000
Charles
Farquhar
Giles
Rolls
Ankura Consulting (Europe) (Debt Financial
Adviser) Tel : +44
(0)20 7469 1111
Alistair
Dick
FTI
Consulting
Tel: +44 (0)20 3727 1051
Tom
Blackwell
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDLVLLFZQLFBBF